News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Lynn McRoy

Articles by Lynn McRoy

10 Real-World Effectiveness of Palbociclib (PAL) Plus Aromatase Inhibitors (AI) in Patients With Metastatic Breast Cancer (MBC) and Cardiovascular Diseases (CVD)

10 Real-World Effectiveness of Palbociclib (PAL) Plus Aromatase Inhibitors (AI) in Patients With Metastatic Breast Cancer (MBC) and Cardiovascular Diseases (CVD)

ByAdam M. Brufsky, MD, PhD,Xianchen Liu,Benjamin Li,Lynn McRoy,Connie Chen,Doris Makari,Rachel M. Layman,Hope S. Rugo, MD

August 20th 2024

11 Real-world Treatment Patterns and Effectiveness of Palbociclib Plus an Aromatase Inhibitor in Patients With Metastatic Breast Cancer Aged 75 Years or Above

ByAdam M. Brufsky, MD, PhD,Xianchen Liu,Benjamin Li,Lynn McRoy,Connie Chen,Rachel M. Layman,Hope S. Rugo, MD

April 28th 2023

49 Financial Toxicity Among Patients With Breast Cancer During the COVID-19 Pandemic

ByYan Wu,Xianchen Liu,Martine C. Maculaitis,Benjamin Li,Alexa Berk,Angelina Massa,Marisa C. Weiss,Lynn McRoy

April 26th 2023

18 Psychosocial Wellbeing and Health Care Resource Utilization Among Patients With Breast Cancer During COVID-19

ByMartine C. Maculaitis,Xianchen Liu,Alexandra Berk,Angelina Massa,Marisa C. Weiss,Samantha M. Kurosky,Benjamin Li,Lynn McRoy

May 6th 2022

Latest Updated Articles

11 Real-world Treatment Patterns and Effectiveness of Palbociclib Plus an Aromatase Inhibitor in Patients With Metastatic Breast Cancer Aged 75 Years or Above
April 28th 2023

Trending on CancerNetwork

Low-Dose CT Screening Reduces Lung Cancer–Specific Mortality

Osimertinib Combo Boosts PFS in EGFR/TP53+ NSCLC Trial

FDA Approves Companion Diagnostic for Pembrolizumab in Esophageal/GEJ Carcinoma

Novel Small Molecule Earns FDA Fast Track Designation in ALK+ NSCLC

Durvalumab/SBRT May Limit Tumor Progression in Early-Stage NSCLC